Q2 2021 Earnings Forecast for U.S. Physical Therapy, Inc. (NYSE:USPH) Issued By Jefferies Financial Group


Share on StockTwits

U.S. Physical Therapy, Inc. (NYSE:USPH) – Analysts at Jefferies Financial Group cut their Q2 2021 earnings estimates for U.S. Physical Therapy in a research report issued to clients and investors on Monday, May 3rd. Jefferies Financial Group analyst B. Tanquilut now expects that the company will earn $0.74 per share for the quarter, down from their previous estimate of $0.85. Jefferies Financial Group has a “Buy” rating and a $135.00 price objective on the stock. Jefferies Financial Group also issued estimates for U.S. Physical Therapy’s Q3 2021 earnings at $0.71 EPS, Q4 2021 earnings at $0.75 EPS, Q1 2022 earnings at $0.68 EPS, Q2 2022 earnings at $0.76 EPS, Q3 2022 earnings at $0.73 EPS, Q4 2022 earnings at $0.77 EPS, Q1 2023 earnings at $0.67 EPS and FY2023 earnings at $3.27 EPS.

A number of other analysts have also recently weighed in on USPH. Zacks Investment Research cut shares of U.S. Physical Therapy from a “hold” rating to a “strong sell” rating in a research note on Wednesday, April 28th. Barrington Research restated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, March 4th.

Shares of U.S. Physical Therapy stock opened at $117.58 on Tuesday. The firm has a fifty day simple moving average of $111.50 and a 200-day simple moving average of $114.23. The company has a current ratio of 0.89, a quick ratio of 0.89 and a debt-to-equity ratio of 0.03. U.S. Physical Therapy has a 1-year low of $64.30 and a 1-year high of $143.67. The stock has a market capitalization of $1.52 billion, a price-to-earnings ratio of 50.03 and a beta of 1.45.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Thursday, February 25th. The company reported $0.85 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.83 by $0.02. The company had revenue of $117.47 million during the quarter, compared to the consensus estimate of $118.08 million. U.S. Physical Therapy had a net margin of 7.21% and a return on equity of 11.20%.

The firm also recently announced a quarterly dividend, which was paid on Friday, April 9th. Shareholders of record on Friday, March 12th were given a dividend of $0.35 per share. The ex-dividend date of this dividend was Thursday, March 11th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.32. This represents a $1.40 dividend on an annualized basis and a yield of 1.19%. U.S. Physical Therapy’s dividend payout ratio is presently 49.65%.

In other news, Director Harry S. Chapman purchased 1,000 shares of the business’s stock in a transaction that occurred on Thursday, March 25th. The shares were acquired at an average cost of $108.00 per share, for a total transaction of $108,000.00. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Edward L. Kuntz sold 1,600 shares of the stock in a transaction that occurred on Monday, March 15th. The shares were sold at an average price of $121.73, for a total transaction of $194,768.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 10,800 shares of company stock worth $1,246,748. Corporate insiders own 2.00% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the business. M&T Bank Corp lifted its stake in U.S. Physical Therapy by 1.6% in the fourth quarter. M&T Bank Corp now owns 4,992 shares of the company’s stock valued at $601,000 after buying an additional 81 shares during the period. Nisa Investment Advisors LLC lifted its holdings in U.S. Physical Therapy by 44.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 650 shares of the company’s stock worth $78,000 after purchasing an additional 200 shares in the last quarter. BRYN MAWR TRUST Co lifted its holdings in U.S. Physical Therapy by 0.7% during the 1st quarter. BRYN MAWR TRUST Co now owns 31,490 shares of the company’s stock worth $3,279,000 after purchasing an additional 212 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of U.S. Physical Therapy by 3.0% in the 4th quarter. The Manufacturers Life Insurance Company now owns 7,634 shares of the company’s stock valued at $918,000 after acquiring an additional 221 shares in the last quarter. Finally, Vantage Consulting Group Inc purchased a new position in shares of U.S. Physical Therapy during the 4th quarter valued at about $27,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Read More: No Load Funds

Earnings History and Estimates for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.